Camber debuts generic ColcrysColchicine tablets are indicated for prophylaxis and treatment of gout flares in adults and Familial Mediterranean fever in adults and children aged 4 years old and older. Hikma intros diazepam injection The product is indicated for the management of anxiety, convulsive seizures and alcohol withdrawals. FDA gives Amphastar tentative OK for vasopressin injection Vasostrict has a market value of approximately $856 million for the 12 months ending Sept. 30, 2021, according to IQVIA. Mark Cuban intros online pharmacy offering affordable generics The pharmacy is expected to offer more than 100 generic drugs at an affordable price. Alembic receives tentative nod for 2 generics Alembic has received tentative approval from the Food and Drug Administration for dronedarone tablets and vortioxetine tablets. FDA green-lights Alembic’s generic Comtan Entacapone tablets have a market value of roughly $10.5 million for the 12 months ending September 2021. Lupin obtains FDA approval, tentative OK for 2 generics The Food and Drug Administration approved Lupin’s sevelamer carbonate for oral suspension and gave tentative approval for azilsartan medoxomil tablets. Par launches generic Cuvposa The product is indicated to reduce chronic severe drooling in children ages 3 to 16 years old with neurologic conditions that cause abnormal drooling. Amneal to acquire Saol Therapeutics’ Baclofen franchise The acquisition expands Amneal’s neurology presence into spasticity. U.S. Court of Appeals for the Federal Circuit upholds validity of Novartis’ Gilenya dosage regimen patent Novartis said it expects no generic versions of Gilenya in the U.S. market for at least the next two years. First Previous 110 111 112 113 114 Next Last
